BANB.SW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 11:30):

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide...

Stats
Today's Volume	55 728.00
Average Volume	96 468.00
Market Cap	5.90B
EPS	CHF0 ( 2024-03-06 )
Last Dividend	CHF0 ( N/A )
Next Dividend	CHF0 ( N/A )
P/E	52.43
ATR14	CHF0.101 (0.13%)

Volume Correlation

Long: -0.15 (neutral)

Short: -0.74 (moderate negative)

Signal:(62.306) Neutral

Bachem Holding AG Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Bachem Holding AG Correlation - Currency/Commodity

0.55
( weak )

0.57
( weak )

0.00
( neutral )

0.40
( neutral )

0.63
( weak )

-0.50
( weak negative )

Bachem Holding AG Financials

Annual	2023
Revenue:	CHF577.32M
Gross Profit:	CHF176.96M (30.65 %)
EPS:	CHF1.500

Q4	2023
Revenue:	CHF337.46M
Gross Profit:	CHF118.43M (35.10 %)
EPS:	CHF1.030

Q2	2023
Revenue:	CHF239.86M
Gross Profit:	CHF58.53M (24.40 %)
EPS:	CHF0.460

Q4	2022
Revenue:	CHF296.86M
Gross Profit:	CHF100.50M (33.85 %)
EPS:	CHF0.870

Financial Reports:

No articles found.

Bachem Holding AG

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.